The Myasthenia Gravis Disease Market Size is projected to reach USD 1.97 billion by 2032 at 7.9% CAGR during the forecast period 2023-2032.
Myasthenia Gravis (MG) is a rare autoimmune disorder characterized by muscle weakness and fatigue, impacting the neuromuscular junction. This chronic condition occurs when the immune system mistakenly attacks the receptors responsible for...
0 Commentarios
0 Acciones
131 Views
0 Vista previa
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian